Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy
Abstract:
The present invention relates to compositions and methods for delivery of siRNA to specific cells or tissue. More particularly, the present invention relates to compositions and methods for cell type-specific delivery of anti-HIV siRNAs via fusion to an anti-gp120 aptamer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0